Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 18, 2022

SELL
$9.31 - $11.84 $5,260 - $6,689
-565 Reduced 21.25%
2,094 $23,000
Q4 2020

Feb 04, 2021

BUY
$9.77 - $13.81 $7,786 - $11,006
797 Added 42.8%
2,659 $35,000
Q3 2020

Oct 23, 2020

BUY
$9.32 - $12.02 $8,751 - $11,286
939 Added 101.73%
1,862 $18,000
Q1 2020

May 11, 2020

BUY
$7.5 - $16.8 $6,922 - $15,506
923 New
923 $10,000

Others Institutions Holding VNDA

About Vanda Pharmaceuticals Inc.


  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $278M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Harbor Investment Advisory, LLC Portfolio

Follow Harbor Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbor Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harbor Investment Advisory, LLC with notifications on news.